| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,591 |
1,971 |
$149K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,906 |
2,245 |
$117K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
150 |
136 |
$16K |
| 99215 |
Prolong outpt/office vis |
77 |
62 |
$4K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
62 |
50 |
$4K |
| 95816 |
|
15 |
13 |
$3K |
| 95957 |
|
15 |
13 |
$1K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
23 |
20 |
$1K |
| 99406 |
|
67 |
61 |
$550.18 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
17 |
14 |
$455.91 |
| 96127 |
|
117 |
98 |
$309.70 |
| 92653 |
|
15 |
13 |
$203.62 |
| 98960 |
|
22 |
19 |
$165.98 |
| 92650 |
|
15 |
13 |
$156.00 |
| 96132 |
|
15 |
13 |
$102.08 |
| 93040 |
|
15 |
13 |
$96.79 |
| 95930 |
|
15 |
13 |
$91.19 |
| 96136 |
|
15 |
13 |
$77.16 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
193 |
179 |
$75.01 |
| 96137 |
|
15 |
13 |
$69.42 |
| 89220 |
|
263 |
250 |
$36.98 |
| 3044F |
|
112 |
102 |
$20.00 |
| 3078F |
|
465 |
382 |
$0.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
191 |
178 |
$0.00 |
| 1160F |
|
3,020 |
2,276 |
$0.00 |
| 1159F |
|
3,441 |
2,574 |
$0.00 |
| 3077F |
|
279 |
240 |
$0.00 |
| 3074F |
|
825 |
679 |
$0.00 |
| 1125F |
|
289 |
227 |
$0.00 |
| 99000 |
|
271 |
258 |
$0.00 |
| 1126F |
|
252 |
229 |
$0.00 |
| 3080F |
|
323 |
267 |
$0.00 |
| 3079F |
|
470 |
412 |
$0.00 |
| 1220F |
|
381 |
316 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
114 |
105 |
$0.00 |
| 3075F |
|
52 |
45 |
$0.00 |